Press Releases

and/or
567 News Releases found
Paul K. Paik, MD, Clinical Director, Thoracic Oncology Service
Researchers at MSK published updated data today in the New England Journal of Medicine from the ongoing, single-arm Phase II VISION study evaluating tepotinib as a single agent in patients with advanced non-small cell lung cancer (NSCLC) with MET exon 14 (METex14) skipping alterations.
MSK radiologist reviews a scan
As the height of the COVID-19 outbreak in New York City and the Tri-State area begins to subside, oncologists at Memorial Sloan Kettering Cancer Center (MSK) are urging patients to schedule cancer screenings and treatments now.
Rona Yaeger, MD, Co-First author (on the left) and Sandra Misale PhD, senior author (on the right).
An international team of researchers led by Sandra Misale, research associate at the Sloan Kettering Institute, examined the effects of the experimental cancer drug, AMG510, which targets KRAS G12C cell lines, and found that the efficacy of such KRAS G12C inhibitors is lineage-specific. These findings provide a mechanistic understanding of the differences in response to KRAS G12C inhibitor in lung and colorectal cancers.
ASCO US Map
New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) revealed the effects of Medicaid expansion on cancer death rates on a national scale.
Robbins Award
As we celebrate National Nurses Week, Memorial Sloan Kettering Cancer Center (MSK) and The Robbins Family Foundation recognize seven distinguished nursing staff members for their exemplary service. Each member of this select group is being honored with the inaugural 2020 Robbins Family Award for Nursing Excellence.
MSK Awards & Appointments
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
MSK Octopus
A new mechanical ventilator system designed by anesthesiologists and biomedical engineers at Memorial Sloan Kettering Cancer Center (MSK) has the ability to support two intubated patients simultaneously while compensating for variability in each patient’s size, weight, and pulmonary needs.
Memorial Sloan Kettering Cancer Center (MSK) has joined the COVID-19 Technology Access Framework, a multi-site effort aimed at accelerating the production of essential health-related technologies that will help prevent, diagnose, and treat infections during the COVID-19 pandemic.
Scott Keeney, PhD & Christopher Lima, PhD
Membership is a widely accepted mark of excellence in science and considered one of the highest honors a scientist can receive.
Crisis Vent
A multidisciplinary team at Memorial Sloan Kettering Cancer Center (MSK) has developed a proof-of-concept crisis ventilator intended to provide lifesaving breathing assistance to patients requiring it when more-sophisticated respiratory support equipment is unavailable.